These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11413318)

  • 1. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.
    Casazza JP; Betts MR; Picker LJ; Koup RA
    J Virol; 2001 Jul; 75(14):6508-16. PubMed ID: 11413318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
    Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
    J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
    J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of polyfunctional HIV-specific CD8 T cells in patients responding differently to antiretroviral therapy.
    Casetti R; De Simone G; Sacchi A; Bordoni V; Viola D; Rinaldi A; Agrati C; Gioia C; Martini F
    Int J Immunopathol Pharmacol; 2014; 27(2):291-7. PubMed ID: 25004842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.
    D'Offizi G; Gioia C; Corpolongo A; Martini F; Paganelli R; Volpi I; Sacchi A; Tozzi V; Narciso P; Poccia F
    Int J Immunopathol Pharmacol; 2007; 20(3):473-85. PubMed ID: 17880761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximity of Cytomegalovirus-Specific CD8
    Heath JJ; Fudge NJ; Gallant ME; Grant MD
    Front Immunol; 2018; 9():201. PubMed ID: 29527205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirus.
    Stone SF; Price P; Khan N; Moss PA; French MA
    AIDS; 2005 Mar; 19(6):555-62. PubMed ID: 15802973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection.
    Ortiz GM; Hu J; Goldwitz JA; Chandwani R; Larsson M; Bhardwaj N; Bonhoeffer S; Ramratnam B; Zhang L; Markowitz MM; Nixon DF
    J Virol; 2002 Jan; 76(1):411-5. PubMed ID: 11739706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
    Seth A; Markee J; Hoering A; Sevin A; Sabath DE; Schmitz JE; Kuroda MJ; Lifton MA; Hirsch MS; Collier AC; Letvin NL; McElrath MJ
    J Infect Dis; 2001 Mar; 183(5):722-9. PubMed ID: 11181148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of HIV-specific central and effector memory CD4 and CD8 T cells requires antigen persistence.
    Sester U; Sester M; Köhler H; Pees HW; Gärtner BC; Wain-Hobson S; Bocharov G; Meyerhans A
    AIDS Res Hum Retroviruses; 2007 Apr; 23(4):549-53. PubMed ID: 17451343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J; Schellens IM; van Baarle D
    Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
    Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
    Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
    Di Mascio M; Sereti I; Matthews LT; Natarajan V; Adelsberger J; Lempicki R; Yoder C; Jones E; Chow C; Metcalf JA; Sidorov IA; Dimitrov DS; Polis MA; Kovacs JA
    J Virol; 2006 Mar; 80(6):2665-74. PubMed ID: 16501076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.